Vascular endothelial growth factor in plasma of patients undergoing peripheral angioplasty.

1. Nowak-Gottl U, Auberger K, Gobel U, et al. Inherited defects of the protein C anticoagulant system in childhood thrombo-embolism. Eur J Pediatr 1996; 155: 921-7. 2. Gandrille S, Aiach M. Identification of mutations in 90 of 121 consecutive symptomatic french patients with a type I Protein C deficiency. Blood 1995; 86: 2598-605. 3. Andrew M, Brooker LA, Ginsberg JS, Kelton JG. Clinical problems in anticoagulation therapy. Hematology 1997; 8-28. 4. Dreyfus M, Masterson M, David M, Rivard GE, Muller FM, Kreuz W, Beeg T, Minford A, Allgrove J, Cohen JD. Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency. Semin Thromb Hemost 1995; 21: 371-81. 5. Comp PC, Esmon CT. Generation of fibrinolytic activity by infusion of activated protein C into dogs. J Clin Invest 1981; 68: 1221-8. 6. Monagle P, Andrew M, Halton J, Marlar R, Jardine L, Vegh P, Johnston M, Webber C, Massicotte MP. Homozygous protein C deficiency: description of a new mutation and successful treatment with low molecular weight heparin. Thromb Haemost 1998; 79: 756-61.